Shushan Guo
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Targeting endosomal trafficking-mediated antigen escape to resensitize myeloma to CAR-T therapy.
Journal: Journal for immunotherapy of cancer
Published: February 15, 2026
Corrigendum to "Dihydrocelastrol induces cell death and suppresses angiogenesis through BCR/AP-1/junb signalling in diffuse large B cell lymphoma" [Arch. Biochem. Biophys. 754 (2024) 109929].
Journal: Archives of biochemistry and biophysics
Published: October 29, 2025
METTL16 enhances proteasome inhibitor resistance in multiple myeloma by inhibiting eIF2α-PERK interaction and promoting PSMB5 translation.
Journal: Oncogene
Published: June 23, 2025
Aberrant activation of adenine nucleotide translocase 3 promotes progression and chemoresistance in multiple myeloma dependent on PINK1 transport.
Journal: International journal of biological sciences
Published: August 03, 2024
EZH2 inhibition induces senescence via ERK1/2 signaling pathway in multiple myeloma.
Journal: Acta biochimica et biophysica Sinica
Published: May 28, 2024
Design, synthesis, and biological evaluation of novel 1-amido-2-one-4-thio-deoxypyranose as potential antitumor agents for multiple myeloma.
Journal: Bioorganic & medicinal chemistry
Published: April 06, 2024
Dihydrocelastrol induces cell death and suppresses angiogenesis through BCR/AP-1/junb signalling in diffuse large B cell lymphoma.
Journal: Archives of biochemistry and biophysics
Published: December 07, 2023
Molecular mechanism by which RRM2-inhibitor (cholagogue osalmid) plus bafilomycin A1 cause autophagic cell death in multiple myeloma.
Journal: Archives of biochemistry and biophysics
Published: August 18, 2023
Showing 1-9 of 9
Last Updated: 09/26/2026